Showing results (1471-1480 of 1,568) with videos related to

Sort By:
Pageof 157
Leukemia & Lymphoma|April 5, 2018
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana LinfomiFrancesco Zaja, Flavia Salvi, Maura Rossi, et al.
Nature Communications|July 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapyRobert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang, et al.
European Journal of Haematology|November 6, 2025
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer CentersMarco Picardi, Annamaria Vincenzi, Claudia Giordano, et al.
Hematological Oncology|May 29, 2023
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana LinfomiMaria E Nizzoli, Martina Manni, Chiara Ghiggi, et al.
Nature Communications|July 25, 2022
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCCRobert Saddawi-Konefka, Aoife O'Farrell, Farhoud Faraji, et al.
Nature Medicine|August 7, 2015
Toward understanding and exploiting tumor heterogeneityAsh A Alizadeh, Victoria Aranda, Alberto Bardelli, et al.
Cell|March 5, 2021
An expanded universe of cancer targetsWilliam C Hahn, Joel S Bader, Theodore P Braun, et al.
Leukemia & Lymphoma|July 29, 2021
A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemiaKendra Sweet, Bhavana Bhatnagar, Hartmut Döhner, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancerH Carlo Maurer, Alvaro Garcia-Curiel, Sam R Holmstrom, et al.
The Journal of Experimental Medicine|May 28, 2026
A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancerFrancisca Nunes de Almeida, Alessandro Vasciaveo, Arianna Giacobbe, et al.
Pageof 157